Drugmakers say Biden misguided over vaccine patent waiver

  • 📰 Reuters
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Drugmakers said President Joe Biden's support for waiving patents of COVID-19 vaccines could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world

BioNTech said it took more than a decade to develop its vaccines manufacturing process and replicating it required experienced personnel and a meticulous technology transfer, among several other factors beyond patents., which hopes to release trial results on its messenger ribonucleic acid vaccine as early as this month, said patents were not to blame for supply bottlenecks.U.S.

The DPA is a decades-old U.S. law that prioritised procurement orders related to U.S. national defence, but it has been widely used in non-military crises, such as natural disasters. The U.S. drugmaker said last year it would not enforce its vaccine patents. CureVac said on Thursday it would also not enforce its patents during the pandemic and that it knew of no other developer that would.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Wow, crazy that the drugmakers investigated themselves and found that whatever makes them the most money is the best thing for the world

🤦🏾‍♀️

Yes, rich countries should just do the right thing and share more Corporations should just do the right thing and pay employees living wages and not destroy the environment Rich people should just pay more in taxes because it's the right thing for everyone Mmmhmmmm

Lol

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.